GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 117 filers reported holding GRITSTONE ONCOLOGY INC in Q4 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $61,235 | -11.8% | 35,602 | 0.0% | 0.00% | – |
| Q2 2023 | $69,424 | +5.2% | 35,602 | +123.6% | 0.00% | – |
| Q1 2022 | $66,000 | -67.8% | 15,920 | 0.0% | 0.00% | – |
| Q4 2021 | $205,000 | +16.5% | 15,920 | -2.2% | 0.00% | – |
| Q3 2021 | $176,000 | +18.1% | 16,274 | 0.0% | 0.00% | – |
| Q2 2021 | $149,000 | +12.9% | 16,274 | +16.5% | 0.00% | – |
| Q1 2021 | $132,000 | +116.4% | 13,975 | -9.8% | 0.00% | – |
| Q4 2020 | $61,000 | +117.9% | 15,488 | +47.6% | 0.00% | – |
| Q3 2020 | $28,000 | -60.0% | 10,495 | 0.0% | 0.00% | – |
| Q2 2020 | $70,000 | -2.8% | 10,495 | -15.0% | 0.00% | – |
| Q1 2020 | $72,000 | -35.1% | 12,342 | 0.0% | 0.00% | – |
| Q4 2019 | $111,000 | – | 12,342 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 4,450,638 | $41,970,000 | 8.18% |
| Copernicus Capital Management, LLC | 37,000 | $349,000 | 5.64% |
| EcoR1 Capital, LLC | 3,421,287 | $32,263,000 | 1.43% |
| Palo Alto Investors LP | 2,298,382 | $21,674,000 | 1.24% |
| AlpInvest Partners B.V. | 226,866 | $2,139,000 | 1.06% |
| Stenahm Asset Managment Ltd | 150,000 | $1,415,000 | 1.00% |
| FRAZIER MANAGEMENT LLC | 1,030,878 | $9,721,000 | 0.78% |
| BVF INC/IL | 1,861,239 | $17,551,000 | 0.66% |
| Avidity Partners Management LP | 2,122,064 | $20,011,000 | 0.55% |
| Redmile Group, LLC | 2,448,158 | $23,086,000 | 0.32% |